Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

Toussaint Rouamba,1,* Houreratou Barry,2,* Esperance Ouédraogo,1 Marc Christian Tahita,1 Nobila Valentin Yaméogo,3 Armel Poda,4 Arnaud Eric Diendéré,5 Abdoul-Salam Ouedraogo,4 Innocent Valea,1 Amariane M Koné,2 Cherileila Thiombiano,2 Isidore Traoré,2 Zekiba Tarnagda,1 Serge A Sawado...

Full description

Saved in:
Bibliographic Details
Main Authors: Rouamba T, Barry H, Ouédraogo E, Tahita MC, Yaméogo NV, Poda A, Diendéré AE, Ouedraogo AS, Valea I, Koné AM, Thiombiano C, Traoré I, Tarnagda Z, Sawadogo SA, Gansané Z, Kambiré Y, Sanou I, Barro-Traoré F, Drabo MK, Tinto H
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
sars-cov-2
chloroquine
hydroxychloroquine
azithromycin
safety
virus shedding
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/7f632ff23a39418aa3a1936be47a35e1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/7f632ff23a39418aa3a1936be47a35e1

Similar Items